Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gian M Busetto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Minerva Urology and Nephrology|March 26, 2021
The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: the perspective through bibliometric analysis of an Italian translational working group in uro-oncologyMatteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
Minerva Urology and Nephrology|October 5, 2022
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCGRoberto Contieri, Rodolfo Hurle, Marco Paciotti, et al.
Minerva Urology and Nephrology|January 13, 2021
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter studyMatteo Ferro, Michele Marchioni, Giuseppe Lucarelli, et al.
Minerva Urology and Nephrology|December 3, 2024
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approachMatteo Ferro, Octavian S Tataru, Giuseppe Fallara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Minerva Urology and Nephrology|March 26, 2021
The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: the perspective through bibliometric analysis of an Italian translational working group in uro-oncologyMatteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
Minerva Urology and Nephrology|October 5, 2022
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCGRoberto Contieri, Rodolfo Hurle, Marco Paciotti, et al.
Minerva Urology and Nephrology|January 13, 2021
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter studyMatteo Ferro, Michele Marchioni, Giuseppe Lucarelli, et al.
Minerva Urology and Nephrology|December 3, 2024
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approachMatteo Ferro, Octavian S Tataru, Giuseppe Fallara, et al.
Pageof 1